Author

My Nguyen Bach

University of New Mexico

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:GWAS summary statistics· 1 Organism:human· 1

Frequent Co-Authors

Avinash D SahuiD· 2 shared David ArredondoiD· 2 shared Kushal Virupakshappa· 2 shared Luis E. Tafoya· 2 shared Oladimeji Macaulay· 2 shared Ala JararwehiD· 1 shared Debjani Patangia Hudgens· 1 shared Deepali L. KundnaniiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Avinash D SahuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintOct 29, 2026

MutQA: A Cross-Validated Q&A Dataset for Genetic Mutations

Robert McCourt, David Arredondo, Oladimeji Macaulay…·Avinash D Sahu

The paper introduces MutQA, a cross-validated Q&A dataset linking genetic mutations to their functional consequences, and demonstrates its utility in improving LLM performance.

DOI 10.64898/2026.10.27.762236

GWAS summary statisticsstatistical model

𝕏 PostBluesky

BioinformaticsbioRxivPreprintOct 17, 2024

DeepVul: A Multi-Task Transformer Model for Joint Prediction of Gene Essentiality and Drug Response

Ala Jararweh, My Nguyen Bach, David Arredondo…·Avinash D Sahu

DeepVul predicts gene essentiality and drug response using a multi-task transformer model trained on cancer transcriptome data, improving precision oncology by identifying treatment vulnerabilities.

DOI 10.1101/2024.10.17.618944

humanbulk RNA-seq

𝕏 PostBluesky